Utilize este identificador para referenciar este registo: http://hdl.handle.net/10400.16/2183
Registo completo
Campo DCValorIdioma
degois.publication.firstPage141pt_PT
degois.publication.issue2pt_PT
degois.publication.lastPage143pt_PT
degois.publication.locationCanadapt_PT
degois.publication.titleGastroenterology Researchpt_PT
dc.relation.publisherversionhttp://www.gastrores.org/index.php/Gastrores/article/view/806pt_PT
dc.contributor.authorNery, F.-
dc.contributor.authorValadares, D.-
dc.contributor.authorMorais, S.-
dc.contributor.authorTeixeira-Gomes, M.-
dc.contributor.authorDe Gottardi, A.-
dc.date.accessioned2017-09-07T08:45:33Z-
dc.date.available2017-09-07T08:45:33Z-
dc.date.issued2017-04-
dc.identifier.citationGastroenterology Res. 2017 Apr;10(2):141-143pt_PT
dc.identifier.issn1918-2805-
dc.identifier.issn1918-2813-
dc.identifier.urihttp://hdl.handle.net/10400.16/2183-
dc.description.abstractIn acute portal vein thrombosis (APVT) unrelated to cirrhosis, anticoagulant therapy is classically started with low molecular weight heparin or vitamin K antagonists. New direct-acting oral anticoagulants (DOACs) are used in the treatment of venous thrombosis outside the splanchnic vascular bed, but not in the latter. We report a young female with APVT occurring in a non-cirrhotic liver linked to heterozygosity of factor V-Leiden and prothrombin G20210A gene mutations. Rivaroxaban was started, with total recanalization of the left and partial recanalization of the right portal vein branches, without complications. New DOACs do not need daily subcutaneous injections nor routinely blood coagulation control tests, making its use attractive, eventually increasing patient's compliance. If proved to be safe and effective in the future studies, its use may be extended to PVT treatment. This case shows that rivaroxaban was safe, not only prevented the extension of thrombosis in the portal tract, but also resolved PVT, at least partially.pt_PT
dc.language.isoengpt_PT
dc.publisherElmer Presspt_PT
dc.rightsopenAccesspt_PT
dc.subjectAnticoagulationpt_PT
dc.subjectDirect-acting oral anticoagulantspt_PT
dc.subjectPortal vein thrombosispt_PT
dc.titleEfficacy and Safety of Direct-Acting Oral Anticoagulants Use in Acute Portal Vein Thrombosis Unrelated to Cirrhosispt_PT
dc.typearticlept_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.peerreviewedyespt_PT
degois.publication.volume10pt_PT
dc.identifier.doi10.14740/gr806wpt_PT
Aparece nas colecções:SHC - Artigos publicados em revistas indexadas na Medline
SRD - Artigos publicados em revistas indexadas na Medline
SCI1- Artigos publicados em revistas indexadas na Medline

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
Efficacy and Safety of Direct-Acting Oral Anticoagulants.pdf815,59 kBAdobe PDFVer/Abrir


FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote Degois 

Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.